Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Advanced Cancer”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Not applicableLooking for participantsNCT07173868
What this trial is testing

FDG PET-CT in Advanced Breast Cancer

Who this might be right for
Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment AvailableIf There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center 100
Large-scale testing (Phase 3)Ended earlyNCT00412776
What this trial is testing

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more
Sesen Bio, Inc. 165
Early research (Phase 1)Active Not RecruitingNCT07749703
What this trial is testing

A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 346
Early research (Phase 1)Study completedNCT01795586
What this trial is testing

A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast Patients

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 19
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Testing effectiveness (Phase 2)Study completedNCT00753714
What this trial is testing

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 124
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28
Not applicableUnknownNCT04440605
What this trial is testing

Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis

Who this might be right for
Gastric CancerGastric Cancer StageCT+1 more
Peking University 968
Early research (Phase 1)Study completedNCT01165905
What this trial is testing

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Traws Pharma, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT00237900
What this trial is testing

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Who this might be right for
Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
AstraZeneca 34
Early research (Phase 1)Study completedNCT00736372
What this trial is testing

A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerAdvanced Cancer
Cascadian Therapeutics Inc. 14
Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5
Early research (Phase 1)Study completedNCT05159518
What this trial is testing

PRT2527 in Participants With Advanced Solid Tumors

Who this might be right for
SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more
Prelude Therapeutics Incorporated 30
Early research (Phase 1)Study completedNCT00338026
What this trial is testing

A Phase I Study of ECO-4601 in Patients With Advanced Cancer

Who this might be right for
TumorsGliomaColorectal Cancer+5 more
Thallion Pharmaceuticals 26
Early research (Phase 1)Study completedNCT02036281
What this trial is testing

Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Who this might be right for
Terminally IllHistologically-confirmed Advanced CancerPain, Intractable
University of Texas Southwestern Medical Center 23
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Next Page